About
Solaxa is a clinical-stage biopharmaceutical company developing therapies aimed at restoring nerve function lost due to neurodegenerative diseases and nerve damage.
Explore Solaxa's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.